Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a nurse coach couples back to intimacy after prostate cancer?

NCT ID NCT07829367

NEW Symptom relief Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers are testing a six-week, nurse-led program that helps Chinese prostate cancer survivors and their female partners talk about sex, rebuild intimacy, and cope together after treatment. About 72 couples join the study, with half receiving the program plus standard survivorship care and half receiving standard care alone. The trial measures whether couples complete the program, how acceptable and safe it is, and whether it shows early signs of improving sexual function, communication, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a culturally tailored, nurse-led couples psychosexual program combining education, communication coaching, mindfulness, and intimacy exercises
What this could lead to
If it works, this program could give prostate cancer survivors and their partners a practical, nurse-delivered way to rebuild intimacy and sexual wellbeing after treatment.
What could go wrong
This is a small feasibility trial of 72 couples, so it is designed to test whether the program can be delivered and tolerated, not to prove it works. Any benefits seen would need confirmation in a much larger trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 72 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Sep 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male prostate cancer survivors: * Diagnosed with localized prostate cancer and aged 18 years or older. * Completed primary prostate cancer treatment at least 12 months before enrollment and are not currently receiving active curative treatment, including surgery, chemotherapy, or radiotherapy. * May be receiving adjuvant androgen deprivation therapy if clinically stable. * Are followed by the urology, surgery, or oncology team at Prince of Wales Hospital or Queen Mary Hospital. * Are willing to participate in the study. * Are in a committed relationship with a female partner who is willing to participate. * Can read Chinese and communicate in Cantonese. * Are physically able to participate in study sessions. * Have no severe cognitive impairment or uncontrolled psychiatric or medical condition that would prevent participation. * Provide written informed consent. Female partners: * Are the current female partner of an eligible prostate cancer survivor participating in the study. * Are aged 18 years or older. * Are willing to participate. * Can read Chinese and communicate in Cantonese. * Are physically and cognitively able to participate. * Provide written informed consent. Dyad-level requirements: * Both members of the couple agree to participate. * Both members are willing to discuss experiences related to sexual recovery, intimacy, relationship adjustment, or couple communication after prostate cancer treatment. Exclusion Criteria: * Either member of the couple: * Is receiving structured psychosexual therapy targeting outcomes similar to those addressed in Dyadic STEP-SexPCare. * Has severe cognitive impairment or uncontrolled psychiatric illness. * Has major medical instability that would interfere with participation. * Has active safety concerns requiring specialist intervention. Prostate cancer survivor-specific exclusions: * Metastatic or terminal disease. * Currently receiving active curative treatment. * Severe communication or functional limitations that preclude participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prostate cancer patients are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

physiological sexual disorder prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prostate cancer patients Sexual dysfunctions

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.